The prohibition of drugs through sumptuary legislation or religious law is a common means of attempting to prevent the recreational use of certain intoxicating substances.
Proposition 215, or the Compassionate Use Act of 1996, is a California law permitting the use of medical cannabis despite marijuana's lack of the normal Food and Drug Administration testing for safety and efficacy. It was enacted, on November 5, 1996, by means of the initiative process, and passed with 5,382,915 (55.6%) votes in favor and 4,301,960 (44.4%) against.
The Office of National Drug Control Policy (ONDCP) is a component of the Executive Office of the President of the United States.
Drug czar is an informal name for the person who directs drug-control policies in various areas. The term follows the informal use of the term czar in U.S. politics. The 'drug czar' title first appeared in a 1982 news story by United Press International that reported that, "[United States] Senators ... voted 62–34 to establish a 'drug czar' who would have overall responsibility for U.S. drug policy." Since then, several ad hoc executive positions established in both the United States and United Kingdom have subsequently been referred to in this manner.
The Drug Policy Alliance (DPA) is a New York City–based nonprofit organization that seeks to advance policies that "reduce the harms of both drug use and drug prohibition, and to promote the sovereignty of individuals over their minds and bodies". The organization prioritizes reducing the role of criminalization in drug policy, advocating for the legal regulation of marijuana, and promoting health-centered drug policies.
Commonly-cited arguments for and against the prohibition of drugs include the following:
The Law Enforcement Action Partnership (LEAP), formerly Law Enforcement Against Prohibition, is a U.S.-based nonprofit organization group of current and former police, judges, prosecutors, and other criminal justice professionals who use their expertise to advance drug policy and criminal justice solutions that enhance public safety. The organization is modeled after Vietnam Veterans Against the War. As of April 2017, they have more than 180 representatives around the world who speak on behalf of over 5,000 law enforcement members and 100,000 supporters.
In the United States, the non-medical use of cannabis is legalized in 24 states and decriminalized in 7 states, as of November 2023. Decriminalization refers to a policy of reduced penalties for cannabis offenses, typically involving a civil penalty for possessing small amounts, instead of criminal prosecution or the threat of arrest. In jurisdictions without penalty the policy is referred to as legalization, although the term decriminalization is sometimes used for this purpose as well.
Drug liberalization is a drug policy process of decriminalizing, legalizing, or repealing laws that prohibit the production, possession, sale, or use of prohibited drugs. Variations of drug liberalization include drug legalization, drug relegalization, and drug decriminalization. Proponents of drug liberalization may favor a regulatory regime for the production, marketing, and distribution of some or all currently illegal drugs in a manner analogous to that for alcohol, caffeine and tobacco.
The Lindesmith Center was an Open Society Institute project which has conducted research related to drug reform. It was founded in 1994 by Ethan Nadelmann with financial support from George Soros. The Center conducted some NIDA-funded studies on harm reduction.
The use, sale, and possession of cannabis containing over 0.3% THC by dry weight in the United States, despite laws in many states permitting it under various circumstances, is illegal under federal law. As a Schedule I drug under the federal Controlled Substances Act (CSA) of 1970, cannabis containing over 0.3% THC by dry weight is considered to have "no accepted medical use" and a high potential for abuse and physical or psychological dependence. Cannabis use is illegal for any reason, with the exception of FDA-approved research programs. However, individual states have enacted legislation permitting exemptions for various uses, including medical, industrial, and recreational use.
This is a history of drug prohibition in the United States.
California Proposition 19 was a ballot initiative on the November 2, 2010, statewide ballot. It was defeated, with 53.5% of California voters voting "No" and 46.5% voting "Yes." If passed, it would have legalized various marijuana-related activities, allowed local governments to regulate these activities, permitted local governments to impose and collect marijuana-related fees and taxes, and authorized various criminal and civil penalties. In March 2010, it qualified to be on the November statewide ballot. The proposition required a simple majority in order to pass, and would have taken effect the day after the election. Yes on 19 was the official advocacy group for the initiative and California Public Safety Institute: No On Proposition 19 was the official opposition group.
Washington Initiative 502 (I-502) "on marijuana reform" was an initiative to the Washington State Legislature, which appeared on the November 2012 general ballot, passing by a margin of approximately 56 to 44 percent. Originally submitted to the Washington Secretary of State during the summer of 2011, enough signatures were collected and submitted by December to meet the required 241,153 signatures, sending it to the legislature. When the legislature adjourned without action in April, Initiative 502 automatically advanced to the November 2012 general ballot. It was approved by popular vote on November 6, and took effect over the course of a year, beginning with certification no later than December 6, 2012. Along with a similar Colorado measure, Initiative 502 was credited for encouraging voter turnout of 81%, the highest in the nation.
The Ending Federal Marijuana Prohibition Act is a series of federal marijuana decriminalization bills that have been introduced multiple times in the United States Congress.
Doctors for Drug Policy Reform, or D4DPR is a 501(c)(3) non-profit organization that serves as a global voice for licensed health professionals and scientists advocating for evidence-based drug policies and best practices that advance public health, reduce stigma, and minimize harm. D4DPR leverage the expertise, compassion, and influence of licensed health professionals to enact changes in drug policy necessary to improve public health, human rights, social justice, and consumer protections. D4DPR, formerly DFCR, was founded in 2015 by David L. Nathan. In 2021, Dr. Bryon Adinoff, an addictionologist, researcher, and editor-in-chief of the American Journal of Drug and Alcohol Abuse succeeded Nathan to become D4DPR's second president.
The use of cannabis as a recreational drug has been outlawed in many countries for several decades. As a result of long-fought legalization efforts, several countries such as Uruguay and Canada, as well as several states in the US, have legalized the production, sale, possession, and recreational and/or medical usage of cannabis. The broad legalization of cannabis in this fashion can have numerous effects on the economy and society in which it is legalized.
The Cannabis Act (C-45) of June, 2018 paved the way for the legalization of cannabis in Canada on 17 October 2018. Police and prosecution services in all Canadian jurisdictions are currently capable of pursuing criminal charges for cannabis marketing without a licence issued by Health Canada. The Supreme Court of Canada has held that the federal Parliament has the power to criminalize the possession of cannabis and that doing so does not infringe upon the Canadian Charter of Rights and Freedoms. The Ontario Court of Appeal and the Superior Court of Ontario have, however, held that the absence of a statutory provision for medical marijuana is unconstitutional, and to that extent the federal law is of no force and/or effect if a prescription is obtained. The recreational use of cannabis has been legalized by the federal government, and took effect on 17 October 2018.
Terms related to cannabis include:
Clergy for a New Drug Policy (CNDP) is an American organization of religious leaders which seeks to reform drug laws in the interest of social justice. The group was begun in 2015 by Chicago United Church of Christ pastor Reverend Al Sharp. They focus on the adverse effects of the War on Drugs including how it has disproportionately impacted low income and minority communities, specifically African Americans. Instead of punishment for drug users, which they have pointed out has not worked in reducing drug usage and crimes within the United States, the organization advocates for a rehabilitation-focused method of fighting addiction. They cite programs like Vancouver's “Insite Supervised Injection Site”, which provides drug addicts with clean needles, medical care, and access to addiction therapists as inspiration for the organization's policy. CNDP initiatives also practice the Four Pillars Drug Strategy first established in Europe, which focuses on four principles: harm reduction, prevention, treatment, and enforcement. While the group focuses primarily on drug reform (mainly Marijuana regulation and legalization), they also look for this change in policy to be a part of a greater movement focusing on social equity and prison reform, including tackling recidivism. The group is composed of members of Catholic, Quaker, Muslim, Protestant, Jewish and Unitarian Universalist clergy.
